Co-Diagnostics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | — | $496.5K |
| Jun 2017 | — | $-4.4M | $116.8K |
| Sep 2017 | — | $5.2M | $4.6M |
| Dec 2017 | — | $3.9M | $3.5M |
| Mar 2018 | — | $2.6M | $2.5M |
| Jun 2018 | — | $1.2M | $1.5M |
| Sep 2018 | — | $127.4K | $2.2M |
| Dec 2018 | $1.9M | $-1.1M | $950.2K |
| Mar 2019 | — | $5.6M | $5.4M |
| Jun 2019 | — | $4.8M | $3.9M |
| Sep 2019 | — | $3.3M | $2.5M |
| Dec 2019 | — | $1.7M | $893.1K |
| Mar 2020 | — | $19.2M | $17.4M |
| Jun 2020 | — | $35.7M | $18.6M |
| Sep 2020 | — | $52.8M | $21.2M |
| Dec 2020 | — | $66.7M | $43.0M |
| Mar 2021 | — | $76.3M | $57.8M |
| Jun 2021 | — | $87.3M | $70.3M |
| Sep 2021 | — | $100.2M | $82.7M |
| Dec 2021 | — | $134.5M | $88.6M |
| Mar 2022 | — | $147.7M | $97.4M |
| Jun 2022 | — | $144.5M | $86.0M |
| Sep 2022 | — | $134.9M | $81.5M |
| Dec 2022 | — | $114.5M | $23.0M |
| Mar 2023 | — | $110.6M | $6.4M |
| Jun 2023 | — | $103.4M | $13.8M |
| Sep 2023 | — | $99.5M | $10.2M |
| Dec 2023 | — | $85.6M | $14.9M |
| Mar 2024 | — | $78.4M | $23.1M |
| Jun 2024 | — | $72.4M | $13.9M |
| Sep 2024 | — | $63.8M | $10.8M |
| Dec 2024 | — | $53.9M | $2.9M |
| Mar 2025 | — | $47.5M | $1.9M |
| Jun 2025 | — | $40.7M | $11.1M |
| Sep 2025 | — | $39.8M | $11.4M |
| Dec 2025 | — | $20.6M | $11.9M |
| Mar 2026 | — | $16.0M | $8.2M |
| Jun 2026 | — | $12.7M | $3.6M |